Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 9 | 2024 | 3655 | 0.520 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 10 | 2024 | 5389 | 0.480 |
Why?
|
Lung Neoplasms | 16 | 2024 | 13451 | 0.450 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2017 | 296 | 0.440 |
Why?
|
Mutation | 19 | 2024 | 30198 | 0.400 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2017 | 617 | 0.350 |
Why?
|
NF-kappa B | 1 | 2017 | 2485 | 0.300 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2887 | 0.270 |
Why?
|
Molecular Targeted Therapy | 6 | 2024 | 2822 | 0.270 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2006 | 40 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 7 | 2024 | 5696 | 0.260 |
Why?
|
Ovarian Neoplasms | 4 | 2025 | 4900 | 0.260 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2023 | 1761 | 0.250 |
Why?
|
Leishmania donovani | 1 | 2006 | 68 | 0.250 |
Why?
|
Carcinoma | 1 | 2017 | 2312 | 0.250 |
Why?
|
Sequence Analysis, Protein | 1 | 2006 | 261 | 0.240 |
Why?
|
Models, Chemical | 1 | 2006 | 608 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5337 | 0.220 |
Why?
|
Angiopoietin-2 | 1 | 2025 | 187 | 0.220 |
Why?
|
Drug Discovery | 1 | 2011 | 1064 | 0.210 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2024 | 77 | 0.210 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1084 | 0.210 |
Why?
|
Colorectal Neoplasms | 4 | 2025 | 6942 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2016 | 4044 | 0.200 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2024 | 266 | 0.200 |
Why?
|
Neoplasms | 5 | 2024 | 22340 | 0.190 |
Why?
|
Models, Molecular | 3 | 2016 | 5379 | 0.190 |
Why?
|
Sequence Alignment | 1 | 2006 | 2171 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1758 | 0.190 |
Why?
|
Aneuploidy | 2 | 2023 | 578 | 0.180 |
Why?
|
Alkylating Agents | 1 | 2021 | 134 | 0.180 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 904 | 0.180 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1624 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 220 | 0.170 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 146 | 0.160 |
Why?
|
Computational Biology | 1 | 2011 | 3559 | 0.160 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 196 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 212 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2022 | 330 | 0.150 |
Why?
|
Arginase | 1 | 2019 | 81 | 0.150 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3946 | 0.150 |
Why?
|
Papillomavirus Infections | 2 | 2023 | 1640 | 0.150 |
Why?
|
bcl-X Protein | 1 | 2019 | 414 | 0.140 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2017 | 38 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 909 | 0.140 |
Why?
|
Proteins | 1 | 2011 | 5995 | 0.130 |
Why?
|
Glioma | 2 | 2022 | 3493 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1142 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 561 | 0.130 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6364 | 0.130 |
Why?
|
Viral Matrix Proteins | 1 | 2017 | 192 | 0.120 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5783 | 0.120 |
Why?
|
Receptors, Mitogen | 1 | 2015 | 61 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 228 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 578 | 0.120 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 626 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5849 | 0.120 |
Why?
|
Myeloproliferative Disorders | 1 | 2021 | 616 | 0.120 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2045 | 0.120 |
Why?
|
Receptor, Notch1 | 2 | 2016 | 517 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 916 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 703 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5444 | 0.120 |
Why?
|
Receptor, Notch2 | 1 | 2015 | 90 | 0.120 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2015 | 95 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1151 | 0.110 |
Why?
|
Exons | 1 | 2020 | 2391 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2019 | 839 | 0.110 |
Why?
|
Signal Transduction | 1 | 2017 | 23601 | 0.110 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 394 | 0.110 |
Why?
|
Cell Line, Tumor | 9 | 2021 | 17075 | 0.100 |
Why?
|
Humans | 43 | 2025 | 765968 | 0.100 |
Why?
|
Serine | 1 | 2016 | 824 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1608 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8611 | 0.100 |
Why?
|
Phenylcarbamates | 1 | 2011 | 38 | 0.100 |
Why?
|
Genomics | 6 | 2024 | 5929 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2011 | 29 | 0.090 |
Why?
|
Base Sequence | 3 | 2022 | 12403 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2047 | 0.090 |
Why?
|
Tosyl Compounds | 1 | 2011 | 115 | 0.090 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1078 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2016 | 734 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59489 | 0.090 |
Why?
|
Transcription Factors | 3 | 2021 | 12131 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2567 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9071 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2844 | 0.080 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 385 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2025 | 11868 | 0.080 |
Why?
|
Aged | 16 | 2025 | 171117 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20124 | 0.080 |
Why?
|
Databases, Protein | 1 | 2011 | 391 | 0.080 |
Why?
|
Glioblastoma | 1 | 2024 | 3459 | 0.080 |
Why?
|
Gene Amplification | 2 | 2024 | 1091 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2016 | 595 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4772 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9373 | 0.070 |
Why?
|
Middle Aged | 16 | 2025 | 223009 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2942 | 0.070 |
Why?
|
Genome, Human | 2 | 2020 | 4448 | 0.070 |
Why?
|
Software | 1 | 2021 | 4462 | 0.070 |
Why?
|
Apoptosis | 2 | 2021 | 9514 | 0.070 |
Why?
|
Protein Kinase C | 1 | 2011 | 1202 | 0.070 |
Why?
|
Protein Binding | 2 | 2011 | 9296 | 0.070 |
Why?
|
Male | 19 | 2025 | 363698 | 0.070 |
Why?
|
Indoles | 2 | 2011 | 1839 | 0.060 |
Why?
|
Female | 18 | 2025 | 396112 | 0.060 |
Why?
|
DNA Helicases | 2 | 2021 | 852 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2878 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9525 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3608 | 0.060 |
Why?
|
Angiopoietin-1 | 1 | 2025 | 132 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 99 | 0.060 |
Why?
|
Adult | 13 | 2025 | 223044 | 0.050 |
Why?
|
Prognosis | 5 | 2023 | 29922 | 0.050 |
Why?
|
Mice | 9 | 2024 | 81819 | 0.050 |
Why?
|
Young Adult | 7 | 2024 | 59889 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4424 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 16047 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2745 | 0.050 |
Why?
|
Species Specificity | 1 | 2006 | 2406 | 0.050 |
Why?
|
Sulfonamides | 1 | 2011 | 1984 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1740 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2921 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13648 | 0.050 |
Why?
|
Animals | 11 | 2024 | 168764 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2023 | 663 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10429 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7421 | 0.040 |
Why?
|
Sucrose | 1 | 2021 | 155 | 0.040 |
Why?
|
Immunotherapy | 1 | 2016 | 4752 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 578 | 0.040 |
Why?
|
Pyrimidines | 1 | 2011 | 3047 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2023 | 800 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10261 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4520 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1066 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11022 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6001 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 433 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1153 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1774 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 614 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2025 | 3737 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 52 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1228 | 0.030 |
Why?
|
Transaminases | 1 | 2016 | 199 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 766 | 0.030 |
Why?
|
Retroelements | 1 | 2016 | 163 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2016 | 219 | 0.030 |
Why?
|
Up-Regulation | 1 | 2024 | 4137 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 541 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1884 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 916 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1892 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2016 | 332 | 0.030 |
Why?
|
Ligands | 1 | 2021 | 3273 | 0.030 |
Why?
|
Chromatin | 2 | 2016 | 2980 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 461 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13400 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 88835 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41649 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2016 | 449 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2054 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1644 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17594 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2593 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21056 | 0.030 |
Why?
|
Azepines | 1 | 2015 | 327 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1753 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1658 | 0.030 |
Why?
|
Glycine | 1 | 2016 | 672 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3624 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 838 | 0.020 |
Why?
|
Computer Simulation | 1 | 2006 | 6255 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2016 | 651 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 1061 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1728 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4108 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3596 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2025 | 65188 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1042 | 0.020 |
Why?
|
Child | 3 | 2024 | 80564 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9601 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2048 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3051 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1505 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2457 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2535 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6499 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1106 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 897 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2010 | 170 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1365 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1885 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1652 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3618 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39193 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 370 | 0.020 |
Why?
|
Tongue Neoplasms | 1 | 2010 | 187 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8041 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18293 | 0.020 |
Why?
|
Niacinamide | 1 | 2010 | 419 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2056 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6220 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2010 | 536 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2589 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3715 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1216 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12795 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11206 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 878 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2010 | 1240 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6832 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5786 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3681 | 0.010 |
Why?
|
Pyrroles | 1 | 2010 | 1119 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26346 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7584 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81514 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36386 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2453 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10033 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42500 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9249 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2888 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22332 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54802 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36532 | 0.000 |
Why?
|